The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute is soliciting offers for the procurement of Medication - Phenburane, a pharmaceutical preparation classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs And Biologicals). This solicitation was posted on December 1, 2025, with a proposal due date of December 12, 2025, providing potential offerors with an 11-day submission window. While the specific contract requirements, qualifications, and evaluation criteria are not detailed in this notice, interested vendors in the pharmaceutical manufacturing sector should prepare comprehensive proposals demonstrating their capability to supply this medication. Potential offerors are advised to monitor the solicitation closely for any amendments or clarifications and to ensure timely submission of their proposals to meet the December 12 deadline.

No set-aside designations have been applied to this procurement opportunity, meaning all eligible vendors regardless of size or business classification may compete. The notice does not identify any incumbent contractors, specific award values, budget ranges, quantities required, service timelines, or place of performance. Vendors seeking additional details regarding contract value, delivery quantities, performance location, or other substantive procurement terms should refer to the full solicitation documents or contact the National Heart Lung and Blood Institute directly for comprehensive contracting information.

Medication - Phenburane

Opportunity facts

About this opportunity

Notice text

Work this opportunity on GovTribe